230 likes | 232 Views
Learn about conservative and surgical treatments for prolapse and urinary incontinence, and when to refer patients to specialists. Save time and money with proper diagnosis and management.
E N D
Keeping the right patients away from hospital Richard Foon Consultant Obstetrician & Gynaecologist Royal Shrewsbury and Telford NHS Trust
Department • Consultants • Other doctors • Continence nurse advisors • Physiotherapists • Urodynamics Team
Uro - gynae - cology • Prolapse • Stress incontinence • Overactive bladder
Prolapse Symptomatic Asymptomatic – no treatment needed Conservative Treatment If stage 1 Pessary Surgery If surgery fails Pessary Mesh
Treatment of Prolapse • Reassure (Conservative, PFMT) • Ring (Pessaries) • Repair (Surgery)
Definitions • Urinary incontinence (symptom): complaint of involuntary loss of urine • Stress (urinary) incontinence: complaint of involuntary loss of urine on effort or physical exertion (e.g. sporting activities), or on sneezing or coughing • Urgency (urinary) incontinence: complaint of involuntary loss of urine associated with urgency
Cured – Up to 50% Stress Incontinence – History, Exam etc Physiotherapy Not cured - Urodynamics Medical tx Urodynamic stress incontinence Macroplastique Surgery Tapes
Costs (based on 100 patients) Savings/Cost Avoidance = £43,008 Personal communication R Freeman 2012
UUI Conservative Treatment Behaviour Modification (Continence advisor) Bladder Re-training Fluid management Pelvic Floor Muscle Training (Physiotherapist) Better supervised’ Compliance Anti-muscarinic drugs Various Preparations Compliance
Anticholinergic drugs Oxybutynin Tolterodine Trospium chloride Solifenacin Fesoterodine Darifenacin
Mirabegron • Mirabegron – A new class of OAB treatment • A first in class β3-adrenoceptor agonist1 • Mirabegron works differently to antimuscarinics1,2 • Gras J. Drugs of Today 2012;48(1):25–32. • Betmiga Summary of Product Characteristics, December 2012. Date of preparation: February 2013. BET13018UK
Special warnings and precautions Use with caution : • autonomic neuropathy • hiatus hernia • clinically significant bladder outflow obstruction • severe constipation • narrow-angle glaucoma; • gastrointestinal obstructive disorders • gastro-oesophageal reflux
Voiding dysfunction • Post void residual - > 30 % of functional bladder capacity • Bladder scan- within 1 minute of void • Residual up to 50 mls • Iatrogenic : Radical pelvic surgery/TVT • Pelvic organ prolapse ( 33% stage 3/4) • Urethral strictures
Who to refer ? • Failed anticholinergics x 2 • Unable to take anticholinergics ( eg: closed angle glaucoma) • Suspicion of other pathology ( Pelvic masses , neurological causes, retention) • Haematuria • Some iatrogenic causes
Who to refer • microscopic haematuria in women aged 50 years and older visible haematuria • recurrent or persisting UTI associated with haematuria in women aged 40 years and older • suspected malignant mass arising from the urinary tract.
Who to refer ? • suspected urogenital fistulae • previous continence surgery • previous pelvic cancer surgery • previous pelvic radiation therapy
Who to refer ? • persisting bladder or urethral pain • clinically benign pelvic masses • associated faecal incontinence • suspected neurological disease • symptoms of voiding difficulty
Take home message • Only treat SYMPTOMATIC prolapse • Physiotherapy • Rule out other causes of overactive bladder symptoms • Frequency / volume charts • Anticholinergics